Cargando…
Hyperbaric Oxygen Therapy Adjuvant Chemotherapy and Radiotherapy through Inhibiting Stemness in Glioblastoma
Glioblastoma multiforme (GBM) is the most common and deadliest primary brain tumor in adults. Despite the advances in GBM treatment, outcomes remain poor, with a 2-year survival rate of less than 5%. Hyperbaric oxygen (HBO) therapy is an intermittent, high-concentration, short-term oxygen therapy us...
Autores principales: | Yuen, Chun-Man, Tsai, Hung-Pei, Tseng, Tzu-Ting, Tseng, Yu-Lung, Lieu, Ann-Shung, Kwan, Aij-Lie, Chang, Alice Y. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605823/ https://www.ncbi.nlm.nih.gov/pubmed/37886967 http://dx.doi.org/10.3390/cimb45100524 |
Ejemplares similares
-
Induction of Mitosis Delay and Apoptosis by CDDO-TFEA in Glioblastoma Multiforme
por: Tsai, Tai-Hsin, et al.
Publicado: (2021) -
Role of Nucleobindin-2 in the Clinical Pathogenesis and Treatment Resistance of Glioblastoma
por: Lin, I-Cheng, et al.
Publicado: (2023) -
Galectin-3 Mediates Tumor Progression in Astrocytoma by Regulating Glycogen Synthase Kinase-3β Activity
por: Tsai, Hung-Pei, et al.
Publicado: (2023) -
Radiotherapy using IMRT boosts after hyperbaric oxygen therapy with chemotherapy for glioblastoma
por: Yahara, Katsuya, et al.
Publicado: (2017) -
miR-3059-3p Regulates Glioblastoma Multiforme Radiosensitivity Enhancement through the Homologous Recombination Pathway of DNA Repair
por: Cheng, Yu-Wen, et al.
Publicado: (2022)